Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28410272 | 0.90 | ALDH1A1 (0.81) | ALDH1A1HPGDTSHRHTTPOLB | |
| SCHEMBL7291481 | 0.84 | ALDH1A1 (0.72) | ALDH1A1HPGDTSHRHTTPOLB | |
| SCHEMBL10572196 | 0.83 | ALDH1A1 (0.71) | ALDH1A1HPGDTSHRHTTPOLB | |
| SCHEMBL8334178 | 0.83 | ALDH1A1 (0.71) | ALDH1A1HPGDTSHRHTTPOLB | |
| SCHEMBL313581 | 0.82 | ALDH1A1 (0.70) | ALDH1A1HPGDTSHRHTTTDP1 | |
| SCHEMBL7734149 | 0.82 | ALDH1A1 (0.70) | ALDH1A1HPGDTSHRHTTPOLB | |
| SCHEMBL6130889 | 0.82 | ALDH1A1 (0.70) | ALDH1A1HPGDTSHRHTTPOLB | |
| SCHEMBL10959778 | 0.82 | ALDH1A1 (0.70) | ALDH1A1HPGDTSHRHTTPOLB | |
| SCHEMBL10867768 | 0.82 | ALDH1A1 (0.70) | ALDH1A1HPGDTSHRHTTPOLB | |
| SCHEMBL3842149 | 0.82 | ALDH1A1 (0.70) | ALDH1A1HPGDTSHRPOLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121076114-B | Lithium iron manganese phosphate/carbon fiber composite positive electrode material and preparation method thereof | 湖南裕能新能源电池材料股份有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-110407788-A | Fluorine-containing skeleton and its synthetic method | UNIV CENTRAL SOUTH | 2019-11-05 | — | — | CN | claimed |
| CN-103483339-B | Simple synthesis method of 9H-pyridino-[2, 3-b] indole | HUAIYIN TEACHER COLLEGE | 2015-03-04 | — | — | CN | claimed |
| CN-103483339-A | Simple synthesis method of 9H-pyridino-[2, 3-b] indole | HUAIYIN TEACHER COLLEGE | 2014-01-01 | — | — | CN | claimed |
| EP-1437749-B1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | RUBYCON CORP (JP) | 2013-07-17 | — | — | EP | claimed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | claimed |
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | claimed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | claimed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | claimed |
| US-20070029529-A1 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | KOMATSU AKIHIKO | 2007-02-08 | — | — | US | claimed |
| CN-1228307-C | O-nitrophenylacetic acid and catalysis synthesis of phase transfer | UNIV TAIYUAN TECHNOLOGY (CN) | 2005-11-23 | — | — | CN | claimed |
| US-20040245105-A1 | Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2004-12-09 | — | — | US | claimed |
| US-20040199002-A1 | Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor | INDUSTRY CO., LTD. (JP) | 2004-10-07 | — | — | US | claimed |
| EP-1437749-A1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-07-14 | — | — | EP | claimed |
| EP-1431278-A1 | PROCESS FOR PRODUCING (2-NITROPHENYL)ACETONITRILE DERIVATIVE AND INTERMEDIATE THEREFOR | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2004-06-23 | — | — | EP | claimed |
| CN-1462738-A | O-nitrophenylacetic acid and catalysis synthesis of phase transfer | TAIYUAN TECHNICAL UNIV (CN) | 2003-12-24 | — | — | CN | claimed |
| EP-0190087-B1 | FORGE-PROOF SECURITY PAPER, PROCESS FOR MAKING A PAPER FORGE-PROOF AND AQUEOUS OR ORGANIC COMPOSITION ESPECIALLY USEFUL IN MAKING A PAPER FORGE-PROOF | AUSSEDAT-REY (FR) | 1988-04-06 | — | — | EP | claimed |
| EP-0190087-A1 | Forge-proof security paper, process for making a paper forge-proof and aqueous or organic composition especially useful in making a paper forge-proof | AUSSEDAT-REY (FR) | 1986-08-06 | — | — | EP | claimed |
| US-4499026-A | Nucleophilic substitution process | ETHYL CORPORATION (US) | 1985-02-12 | — | — | US | claimed |
| JP-55062061-A | — | — | None | — | — | JP | disclosed |
| JP-54126726-A | — | — | None | — | — | JP | disclosed |
| US-20260131016-A1 | NOVEL AURISTATIN ANALOGS AND IMMUNOCONJUGATES THEREOF | ADCENTRX THERAPEUTICS INC (US) | 2026-05-14 | — | — | US | disclosed |
| CN-121076114-B | Lithium iron manganese phosphate/carbon fiber composite positive electrode material and preparation method thereof | 湖南裕能新能源电池材料股份有限公司 | 2026-02-27 | — | — | CN | disclosed |
| EP-3845515-B1 | PRODUCTION METHOD FOR CRYSTAL OF REDUCED COENZYME Q10 HAVING EXCELLENT STABILITY | KANEKA CORP (JP) | 2025-11-12 | — | — | EP | disclosed |
| EP-4131548-B1 | NON-AQUEOUS ELECTROLYTE FOR BATTERY, PRECURSOR FOR LITHIUM SECONDARY BATTERY, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY, PHOSPHAZENE COMPOUND, AND ADDITIVE FOR BATTERY | MITSUI CHEMICALS INC (JP) | 2025-08-27 | — | — | EP | disclosed |
| EP-4426714-A1 | NOVEL AURISTATIN ANALOGS AND IMMUNOCONJUGATES THEREOF | Adcentrx Therapeutics Inc. (US) | 2024-09-11 | — | — | EP | disclosed |
| CN-118541378-A | Novel auristatin analogues and immunoconjugates thereof | 艾德森特克斯治疗股份有限公司 | 2024-08-23 | — | — | CN | disclosed |
| US-11773043-B2 | Systems and methods for producing coenzyme Q10 | Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. (CN) | 2023-10-03 | — | — | US | disclosed |
| CN-114805796-B | Two-dimensional strong fluorescence polyaniline material with metal ion detection performance and preparation method thereof | 武汉大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-110944970-B | For the production of coenzyme Q 10 Systems and methods of (1) | 内蒙古金达威药业有限公司 | 2023-08-01 | — | — | CN | disclosed |
| WO-2023081230-A1 | NOVEL AURISTATIN ANALOGS AND IMMUNOCONJUGATES THEREOF | ADCENTRX THERAPEUTICS INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| US-20230110251-A1 | NON-AQUEOUS ELECTROLYTE FOR BATTERY, PRECURSOR FOR LITHIUM SECONDARY BATTERY, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY, PHOSPHAZENE COMPOUND, AND ADDITIVE FOR BATTERY | MITSUI CHEMICALS, INC. (JP) | 2023-04-13 | — | — | US | disclosed |
| CN-111646908-B | Method for preparing aromatic amine compound | 宜昌尚诺德生物医药科技有限公司 | 2023-03-10 | — | — | CN | disclosed |
| EP-4131548-A1 | NON-AQUEOUS ELECTROLYTE FOR BATTERY, PRECURSOR FOR LITHIUM SECONDARY BATTERY, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY, PHOSPHAZENE COMPOUND, AND ADDITIVE FOR BATTERY | Mitsui Chemicals, Inc. (JP) | 2023-02-08 | — | — | EP | disclosed |
| CN-111732493-B | Synthesis process of arylamine compound | 宜昌尚诺德生物医药科技有限公司 | 2023-01-24 | — | — | CN | disclosed |
| US-11498893-B2 | Production method for crystal of reduced coenzyme Q10 having excellent stability | KANEKA CORPORATION (JP) | 2022-11-15 | — | — | US | disclosed |
| CN-115315840-A | Nonaqueous electrolyte for battery, lithium secondary battery precursor, method for producing lithium secondary battery, phosphazene compound, and battery additive | 三井化学株式会社 | 2022-11-08 | — | — | CN | disclosed |
| WO-2022204150-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | BLUE OAK PHARMACEUTICALS, INC. (US) | 2022-09-29 | — | — | WO | disclosed |
| US-11453633-B2 | Production method for crystal of reduced coenzyme Q10 having excellent stability | KANEKA CORPORATION (JP) | 2022-09-27 | — | — | US | disclosed |
| CN-114931967-A | Preparation method and application of catalyst for preparing arylamine by selective hydrogenation of aromatic nitro compound | 浙江师范大学 | 2022-08-23 | — | — | CN | disclosed |
| US-20210355059-A1 | PRODUCTION METHOD FOR CRYSTAL OF REDUCED COENZYME Q10 HAVING EXCELLENT STABILITY | KANEKA CORPORATION (JP) | 2021-11-18 | — | — | US | disclosed |
| US-20210317057-A1 | PRODUCTION METHOD FOR CRYSTAL OF REDUCED COENZYME Q10 HAVING EXCELLENT STABILITY | KANEKA CORPORATION (JP) | 2021-10-14 | — | — | US | disclosed |
| EP-3845515-A1 | PRODUCTION METHOD FOR CRYSTAL OF REDUCED COENZYME Q10 HAVING EXCELLENT STABILITY | Kaneka Corporation (JP) | 2021-07-07 | — | — | EP | disclosed |
| CN-112839921-A | Method for producing highly stable reduced coenzyme Q10 crystal | 株式会社钟化 | 2021-05-25 | — | — | CN | disclosed |
| US-20210032666-A1 | METHOD FOR PRODUCING COENZYME Q10 | KANEKA CORPORATION (JP) | 2021-02-04 | — | — | US | disclosed |
| CN-111995577-A | Synthetic method of 4-fluoro indazole 3-carbonitrile or derivatives thereof | 上海代为化学科技有限公司 | 2020-11-27 | — | — | CN | disclosed |
| US-10837043-B2 | Method for producing coenzyme Q10 | KANEKA CORPORATION (JP) | 2020-11-17 | — | — | US | disclosed |
| CN-111732493-A | Synthesis process of arylamine compound | 宜昌尚诺德生物医药科技有限公司 | 2020-10-02 | — | — | CN | disclosed |
| CN-111646908-A | Method for preparing aromatic amine compound | 宜昌尚诺德生物医药科技有限公司 | 2020-09-11 | — | — | CN | disclosed |
| US-20200208189-A9 | METHOD FOR PRODUCING COENZYME Q10 | KANEKA CORPORATION (JP) | 2020-07-02 | — | — | US | disclosed |
| CN-106800493-B | Method for reducing aromatic nitro group into aromatic amine | 宜昌尚诺德生物医药科技有限公司 | 2020-06-30 | — | — | CN | disclosed |
| CN-110981825-A | 2-nitrobenzophenones and process for their preparation | 安徽省化工研究院 | 2020-04-10 | — | — | CN | disclosed |
| WO-2020067275-A1 | METHOD FOR PRODUCING REDUCED COENZYME Q10 CRYSTAL HAVING EXCELLENT STABILITY | 株式会社カネカ | 2020-04-02 | — | — | WO | disclosed |
| CN-110944970-A | For producing coenzyme Q10System and method | 内蒙古金达威药业有限公司 | 2020-03-31 | — | — | CN | disclosed |
| US-20200087235-A1 | SYSTEMS AND METHODS FOR PRODUCING COENZYME Q10 | Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. (CN) | 2020-03-19 | — | — | US | disclosed |
| WO-2020045571-A1 | PRODUCTION METHOD FOR CRYSTAL OF REDUCED COENZYME Q10 HAVING EXCELLENT STABILITY | 株式会社カネカ | 2020-03-05 | — | — | WO | disclosed |
| WO-2020029017-A1 | SYSTEMS AND METHODS FOR PRODUCING COENZYME Q10 | Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. (CN) | 2020-02-13 | — | — | WO | disclosed |
| US-10471139-B2 | Toll-like receptor agonists | THE UNIVERSITY OF KANSAS (US) | 2019-11-12 | — | — | US | disclosed |
| CN-110407788-A | Fluorine-containing skeleton and its synthetic method | UNIV CENTRAL SOUTH | 2019-11-05 | — | — | CN | disclosed |
| WO-2019189290-A1 | COENZYME Q10 PRODUCTION METHOD | 株式会社カネカ | 2019-10-03 | — | — | WO | disclosed |
| EP-3480317-A1 | METHOD FOR PRODUCING COENZYME Q10 | Kaneka Corporation (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-20190127773-A1 | METHOD FOR PRODUCING COENZYME Q10 | KANEKA CORPORATION (JP) | 2019-05-02 | — | — | US | disclosed |
| US-10239811-B2 | Process for producing reduced coenzyme Q10 | KANEKA CORPORATION (JP) | 2019-03-26 | — | — | US | disclosed |
| CN-108997129-A | A kind of synthetic method of o-nitrophenyl acetic acid | 江苏师范大学 | 2018-12-14 | — | — | CN | disclosed |
| CN-108752215-A | A kind of synthetic method of o-nitrophenyl acetic acid | 杨程飞扬 | 2018-11-06 | — | — | CN | disclosed |
| EP-2489652-B1 | METHOD FOR PRODUCING REDUCED COENZYME Q10, METHOD FOR STABILIZING SAME, AND COMPOSITION COMPRISING SAME | KANEKA CORP (JP) | 2018-07-25 | — | — | EP | disclosed |
| US-10021877-B2 | Substituted 5-hydroxy-2,3-diphenylpentanonitrile derivatives, processes for their preparation and their use as herbicides and/or plant growth regulators | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-07-17 | — | — | US | disclosed |
| EP-2597156-B1 | METHOD FOR MANUFACTURING A FAT-SOLUBLE BIOACTIVE SUBSTANCE | KANEKA CORP (JP) | 2018-06-27 | — | — | EP | disclosed |
| EP-1583729-B1 | METHOD OF PURIFYING REDUCED COENZYME Q | KANEKA CORP (JP) | 2018-06-06 | — | — | EP | disclosed |
| US-20180134644-A1 | PROCESS FOR PRODUCING REDUCED COENZYME Q10 | KANEKA CORPORATION (JP) | 2018-05-17 | — | — | US | disclosed |
| EP-3321248-A2 | METHOD OF PRODUCING REDUCED COENZYME Q10 USING SOLVENT WITH HIGH OXIDATION-PROTECTIVE EFFECT | Kaneka Corporation (JP) | 2018-05-16 | — | — | EP | disclosed |
| EP-3003036-B1 | SUBSTITUTED 5-HYDROXY-2,3-DIPHENYLPENTANONITRILE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND/OR PLANT GROWTH REGULATORS | BAYER CROPSCIENCE AG (DE) | 2018-04-11 | — | — | EP | disclosed |
| US-9926580-B2 | Process for producing coenzyme Q10 | KANEKA CORPORATION (JP) | 2018-03-27 | — | — | US | disclosed |
| EP-2725004-B1 | REDUCED COENZYME Q10 CRYSTAL HAVING EXCELLENT STABILITY | KANEKA CORP (JP) | 2018-02-28 | — | — | EP | disclosed |
| EP-3279180-A1 | METHOD FOR STABILIZATION OF REDUCED COENZYME Q10 | Kaneka Corporation (JP) | 2018-02-07 | — | — | EP | disclosed |
| EP-1415970-B1 | METHOD OF PRODUCING REDUCED COENZYME Q10 CRYSTALS WITH EXCELLENT HANDLING PROPERTIES | KANEKA CORP (JP) | 2017-12-20 | — | — | EP | disclosed |
| EP-2489653-B1 | METHOD FOR PRODUCING REDUCED COENZYME Q10 AND COMPOSITION COMPRISING SAME | KANEKA CORP (JP) | 2017-11-29 | — | — | EP | disclosed |
| EP-2289866-B1 | METHOD OF PRODUCING REDUCED COENZYME Q10 AS OILY PRODUCT | KANEKA CORP (JP) | 2017-08-30 | — | — | EP | disclosed |
| EP-3197435-A1 | SOLID DRUG FORM OF N-(2,6-BIS(1-METHYLETHYL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTYL) METHYL)UREA HYDROCHLORIDE AND COMPOSITIONS, METHODS AND KITS RELATED THERETO | Millendo Therapeutics, Inc. (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-2017251-B1 | METHOD FOR STABILIZATION OF REDUCED COENZYME Q10 | KANEKA CORP (JP) | 2017-07-19 | — | — | EP | disclosed |
| EP-1415971-B1 | METHOD OF PRODUCING REDUCED COENZYME Q10 AS OILY PRODUCT | KANEKA CORP (JP) | 2017-03-22 | — | — | EP | disclosed |
| US-9556098-B2 | Reduced coenzyme Q10 crystal having excellent stability | KANEKA CORPORATION (JP) | 2017-01-31 | — | — | US | disclosed |
| US-9532957-B2 | Method of stabilizing reduced coenzyme Q10 | KANEKA CORPORATION (JP) | 2017-01-03 | — | — | US | disclosed |
| US-9518004-B2 | Reduced coenzyme Q10 derivative and method for production thereof | KANEKA CORPORATION (JP) | 2016-12-13 | — | — | US | disclosed |
| US-20160304915-A1 | PROCESS FOR PRODUCING COENZYME Q10 | KANEKA CORP (JP) | 2016-10-20 | — | — | US | disclosed |
| US-20160289152-A1 | REDUCED COENZYME Q10 CRYSTAL HAVING EXCELLENT STABILITY | KANEKA CORPORATION (JP) | 2016-10-06 | — | — | US | disclosed |
| US-9440901-B2 | Method for producing reduced coenzyme Q10 | KANEKA CORPORATION (JP) | 2016-09-13 | — | — | US | disclosed |
| CN-105820165-A | Alpha-carboline compounds, preparation method thereof and purpose thereof | 中国科学院上海药物研究所 | 2016-08-03 | — | — | CN | disclosed |
| WO-2016110237-A1 | Α-CARBOLINE COMPOUND , PREPARATION METHOD THEREFOR AND USES THEREOF | 中国科学院上海药物研究所 | 2016-07-14 | — | — | WO | disclosed |
| US-9388109-B2 | Reduced coenzyme Q10 crystal having excellent stability | KANEKA CORPORATION (JP) | 2016-07-12 | — | — | US | disclosed |
| US-20160166681-A1 | TOLL-LIKE RECEPTOR AGONISTS | THE UNIVERSITY OF KANSAS | 2016-06-16 | — | — | US | disclosed |
| US-20160166681-A1 | TOLL-LIKE RECEPTOR AGONISTS | THE UNIVERSITY OF KANSAS | 2016-06-16 | — | — | US | disclosed |
| US-20160166681-A1 | TOLL-LIKE RECEPTOR AGONISTS | THE UNIVERSITY OF KANSAS | 2016-06-16 | — | — | US | disclosed |
| US-20160113277-A1 | Substituted 5-Hydroxy-2,3-Diphenylpentanonitrile Derivatives, Processes For Their Preparation And Their Use As Herbicides And/Or Plant Growth Regulators | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-04-28 | — | — | US | disclosed |
| US-9315839-B2 | Processes for producing coenzyme Q10 | KANEKA CORPORATION (JP) | 2016-04-19 | — | — | US | disclosed |
| EP-3003036-A1 | SUBSTITUTED 5-HYDROXY-2,3-DIPHENYLPENTANONITRILE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND/OR PLANT GROWTH REGULATORS | Bayer CropScience Aktiengesellschaft (DE) | 2016-04-13 | — | — | EP | disclosed |
| WO-2016049518-A1 | SOLID DRUG FORM OF N-(2,6-BIS(1-METHYLETHYL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTYL) METHYL)UREA HYDROCHLORIDE AND COMPOSITIONS, METHODS AND KITS RELATED THERETO | MILLENDO THERAPEUTICS, INC. (US) | 2016-03-31 | — | — | WO | disclosed |
| CN-103025881-B | Process for preparing fat-soluble physiologically active substance | KANEKA CORP. (JP) | 2016-03-30 | — | — | CN | disclosed |
| EP-2947082-A1 | N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS | Pfizer Inc (US) | 2015-11-25 | — | — | EP | disclosed |
| WO-2015162536-A1 | NOVEL PROCESS FOR PREPARATION OF MIRABEGRON AND IT'S INTERMEDIATE | CALYX CHEMICALS AND PHARMACEUTICALS LTD. (IN) | 2015-10-29 | — | — | WO | disclosed |
| US-20150307440-A1 | REDUCED COENZYME Q10 DERIVATIVE AND METHOD FOR PRODUCTION THEREOF | KANEKA CORPORATION (JP) | 2015-10-29 | — | — | US | disclosed |
| US-20150284311-A1 | METHOD FOR PRODUCING REDUCED COENZYME Q10 | KANEKA CORPORATION (JP) | 2015-10-08 | — | — | US | disclosed |
| US-9139587-B2 | N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors | PFIZER INC. (US) | 2015-09-22 | — | — | US | disclosed |
| EP-2676958-B1 | N1-Pyrazolospiroketone acetyl-CoA carboxylase inhibitors | PFIZER (US) | 2015-07-01 | — | — | EP | disclosed |
| CN-104744302-A | Preparation method of 2-(4-aminophenyl)-2-methyl propionitrile compound | SHANGHAI PHARMVALLEY CORP | 2015-07-01 | — | — | CN | disclosed |
| US-9040747-B2 | Method for producing reduced coenzyme Q10, method for stabilizing same, and composition comprising same | KANEKA CORPORATION (JP) | 2015-05-26 | — | — | US | disclosed |
| US-9012230-B2 | Fluorescent nanoprobe for detecting hydrogen peroxide and fabrication method thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2015-04-21 | — | — | US | disclosed |
| CN-102656133-B | Method for producing reduced coenzyme Q10, method for stabilizing same, and composition comprising same | KANEKA CORP | 2015-04-15 | — | — | CN | disclosed |
| US-9006493-B2 | Method for manufacturing a fat-soluble bioactive substance | KANEKA CORPORATION (JP) | 2015-04-14 | — | — | US | disclosed |
| CN-103483339-B | Simple synthesis method of 9H-pyridino-[2, 3-b] indole | HUAIYIN TEACHER COLLEGE | 2015-03-04 | — | — | CN | disclosed |
| WO-2015023958-A1 | TOLL-LIKE RECEPTOR AGONISTS | THE UNIVERSITY OF KANSAS (US) | 2015-02-19 | — | — | WO | disclosed |
| WO-2015023958-A1 | TOLL-LIKE RECEPTOR AGONISTS | THE UNIVERSITY OF KANSAS (US) | 2015-02-19 | — | — | WO | disclosed |
| WO-2014195253-A1 | SUBSTITUTED 5-HYDROXY-2,3-DIPHENYLPENTANONITRILE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND/OR PLANT GROWTH REGULATORS | BAYER CROPSCIENCE AG (DE) | 2014-12-11 | — | — | WO | disclosed |
| CN-102695708-B | N1-pyrazolospiroketone acetyl-coA carboxylase inhibitors | PFIZER INC. (US) | 2014-10-15 | — | — | CN | disclosed |
| US-8853464-B2 | Method of producing reduced coenzyme Q10 crystals with excellent handling properties | KANEKA CORPORATION (JP) | 2014-10-07 | — | — | US | disclosed |
| CN-102381948-B | Method of stabilizing reduced coenzyme Q10 | KANEKA CORP. (JP) | 2014-10-01 | — | — | CN | disclosed |
| US-20140288111-A1 | N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS | PFIZER INC. (US) | 2014-09-25 | — | — | US | disclosed |
| CN-101842340-B | Method for production of reduced coenzyme Q10 using water-containing organic solvent | KANEKA CORP | 2014-08-13 | — | — | CN | disclosed |
| US-8802690-B2 | N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors | PFIZER INC. (US) | 2014-08-12 | — | — | US | disclosed |
| US-20140212402-A1 | METHOD OF STABILIZING REDUCED COENZYME Q10 | KANEKA CORPORATION (JP) | 2014-07-31 | — | — | US | disclosed |
| CN-102056897-B | Sulfonamide compound and application thereof | ASAHI KASEI PHARMA CORP | 2014-05-07 | — | — | CN | disclosed |
| US-20140120073-A1 | REDUCED COENZYME Q10 CRYSTAL HAVING EXCELLENT STABILITY | KANEKA CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| EP-2725004-A1 | REDUCED COENZYME Q10 CRYSTAL HAVING EXCELLENT STABILITY | Kaneka Corporation (JP) | 2014-04-30 | — | — | EP | disclosed |
| US-8703155-B2 | Method of stabilizing reduced coenzyme q10 | KANEKA CORPORATION (JP) | 2014-04-22 | — | — | US | disclosed |
| CN-103635452-A | Reduced coenzyme Q10 crystal having excellent stability | KANEKA CORP | 2014-03-12 | — | — | CN | disclosed |
| CN-102675151-B | Preparation method of nitrophenylacetonitrile compound | BEIJING YINGTAI JIAHE BIOLOG TECHNOLOGY CO LTD | 2014-02-19 | — | — | CN | disclosed |
| CN-102675151-B | Preparation method of nitrophenylacetonitrile compound | BEIJING YINGTAI JIAHE BIOLOG TECHNOLOGY CO LTD | 2014-02-19 | — | — | CN | disclosed |
| CN-103483339-A | Simple synthesis method of 9H-pyridino-[2, 3-b] indole | HUAIYIN TEACHER COLLEGE | 2014-01-01 | — | — | CN | disclosed |
| EP-2186789-B1 | METHOD OF PRODUCING REDUCED COENZYME Q10 AND METHOD OF STABILIZING THE SAME | KANEKA CORP (JP) | 2013-12-25 | — | — | EP | disclosed |
| EP-2676958-A1 | N1-Pyrazolospiroketone acetyl-CoA carboxylase inhibitors | Pfizer Inc. (US) | 2013-12-25 | — | — | EP | disclosed |
| EP-1452174-B1 | STABILIZED COMPOSITION COMPRISING REDUCED COENZYME Q10 | KANEKA CORP (JP) | 2013-12-18 | — | — | EP | disclosed |
| EP-2499139-B1 | N1-PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS | PFIZER (US) | 2013-12-11 | — | — | EP | disclosed |
| US-20130296319-A1 | N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS | PFIZER INC. | 2013-11-07 | — | — | US | disclosed |
| US-8541406-B2 | Thiadiazole derivatives for the treatment of neurodegenerative diseases | NV REMYND (BE) | 2013-09-24 | — | — | US | disclosed |
| EP-2380568-B1 | Method of producing and crystallizing reduced coenzyme Q10 | KANEKA CORP (JP) | 2013-09-11 | — | — | EP | disclosed |
| US-20130225868-A1 | METHOD FOR MANUFACTURING A FAT-SOLUBLE BIOACTIVE SUBSTANCE | KANEKA CORPORATION (JP) | 2013-08-29 | — | — | US | disclosed |
| US-8507681-B2 | N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors | PFIZER INC. (US) | 2013-08-13 | — | — | US | disclosed |
| EP-1437749-B1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | RUBYCON CORP (JP) | 2013-07-17 | — | — | EP | disclosed |
| US-20130142767-A1 | COMPOSITION CONTAINING REDUCED COENZYME Q10, AND MANUFACTURING AND STABILISING METHODS THEREFOR | KENEKA CORPORATION (JP) | 2013-06-06 | — | — | US | disclosed |
| EP-2597156-A1 | METHOD FOR MANUFACTURING A FAT-SOLUBLE BIOACTIVE SUBSTANCE | Kaneka Corporation (JP) | 2013-05-29 | — | — | EP | disclosed |
| US-8445734-B2 | Photolabile protective groups for improved processes to prepare oligonucleotide arrays | NIGU CHEMIE GMBH (DE) | 2013-05-21 | — | — | US | disclosed |
| US-8445734-B2 | Photolabile protective groups for improved processes to prepare oligonucleotide arrays | NIGU CHEMIE GMBH (DE) | 2013-05-21 | — | — | US | disclosed |
| EP-1460660-B1 | ELECTROLYTIC CAPACITOR AND ELECTROLYTIC SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR | RUBYCON CORP (JP) | 2013-04-10 | — | — | EP | disclosed |
| CN-103025881-A | Process for preparing fat-soluble physiologically active substance | KANEKA CORP | 2013-04-03 | — | — | CN | disclosed |
| US-8373160-B2 | Electrophotographic photoreceptor, process cartridge image forming apparatus, and cured film | FUJI XEROX CO., LTD. (JP) | 2013-02-12 | — | — | US | disclosed |
| US-20130030181-A1 | N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors | PFIZER INC. (US) | 2013-01-31 | — | — | US | disclosed |
| CN-101432256-B | Stable reduced coenzyme Q10Method (2) | KANEKA CORP | 2012-11-28 | — | — | CN | disclosed |
| US-20120276651-A1 | FLUORESCENT NANOPROBE FOR DETECTING HYDROGEN PEROXIDE AND FABRICATION METHOD THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2012-11-01 | — | — | US | disclosed |
| US-8288405-B2 | N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors | PFIZER INC. (US) | 2012-10-16 | — | — | US | disclosed |
| EP-2499140-A1 | N2-PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS | Pfizer Inc. (US) | 2012-09-19 | — | — | EP | disclosed |
| EP-2499139-A1 | N1-PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS | Pfizer Inc. (US) | 2012-09-19 | — | — | EP | disclosed |
| CN-102675151-A | Preparation method of nitrophenylacetonitrile compound | BEIJING YINGTAI JIAHE BIOLOG TECHNOLOGY CO LTD | 2012-09-19 | — | — | CN | disclosed |
| CN-102675151-A | Preparation method of nitrophenylacetonitrile compound | BEIJING YINGTAI JIAHE BIOLOG TECHNOLOGY CO LTD | 2012-09-19 | — | — | CN | disclosed |
| US-20120225900-A1 | N2-PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS | PFIZER INC. (US) | 2012-09-06 | — | — | US | disclosed |
| EP-2292592-B1 | SULFONAMIDE COMPOUND AND APPLICATION THEREOF | ASAHI KASEI PHARMA CORP (JP) | 2012-09-05 | — | — | EP | disclosed |
| CN-102656133-A | Method for producing reduced coenzyme Q10, method for stabilizing same, and composition comprising same | KANEKA CORP | 2012-09-05 | — | — | CN | disclosed |
| CN-102656134-A | Method for producing reduced coenzyme Q10, method for stabilizing same, and composition comprising same | KANEKA CORP | 2012-09-05 | — | — | CN | disclosed |
| EP-2489652-A1 | METHOD FOR PRODUCING REDUCED COENZYME Q10, METHOD FOR STABILIZING SAME, AND COMPOSITION COMPRISING SAME | Kaneka Corporation (JP) | 2012-08-22 | — | — | EP | disclosed |
| EP-2489653-A1 | METHOD FOR PRODUCING REDUCED COENZYME Q10, METHOD FOR STABILIZING SAME, AND COMPOSITION COMPRISING SAME | Kaneka Corporation (JP) | 2012-08-22 | — | — | EP | disclosed |
| US-20120207731-A1 | METHOD FOR PRODUCING REDUCED COENZYME Q10, METHOD FOR STABILIZING SAME, AND COMPOSITION COMPRISING SAME | KANEKA CORPORATION (JP) | 2012-08-16 | — | — | US | disclosed |
| US-20120201802-A1 | METHOD FOR PRODUCING REDUCED COENZYME Q10, METHOD FOR STABILIZING SAME, AND COMPOSITION COMPRISING SAME | KENEKA CORPORATION (JP) | 2012-08-09 | — | — | US | disclosed |
| CN-101318889-B | Reduced coenzyme Q10Method for stabilizing | KANEGAFUCHI CHEMICAL IND | 2012-05-30 | — | — | CN | disclosed |
| CN-102381948-A | Method of stabilizing reduced coenzyme Q10 | KANEKA CORP | 2012-03-21 | — | — | CN | disclosed |
| EP-2402303-A2 | A reduced coenzyme Q10 crystal | Kaneka Corporation (JP) | 2012-01-04 | — | — | EP | disclosed |
| US-8063254-B2 | Method for production of reduced coenzyme Q10 using water-containing organic solvent | KANEKA CORPORATION (JP) | 2011-11-22 | — | — | US | disclosed |
| US-20110263906-A1 | METHOD OF PRODUCING REDUCED COENZYME Q10 CRYSTALS WITH EXCELLENT HANDLING PROPERTIES | KANEKA CORPORATION (JP) | 2011-10-27 | — | — | US | disclosed |
| EP-2380568-A1 | Method of producing and crystallizing reduced coenzyme Q10 | KANEKA CORPORATION (JP) | 2011-10-26 | — | — | EP | disclosed |
| WO-2011130395-A1 | INHIBITORS OF FLIP TO TREAT CANCER | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2011-10-20 | — | — | WO | disclosed |
| EP-2377524-A1 | Method of stabilizing reduced coenzyme Q10 | KANEKA CORPORATION (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-8039514-B2 | Sulfonamide compounds and use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20110215303-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE IMAGE FORMING APPARATUS, AND CURED FILM | FUJI XEROX CO., LTD. (JP) | 2011-09-08 | — | — | US | disclosed |
| US-8003828-B2 | Method of producing reduced coenzyme Q10 crystals with excellent handling properties | KANEKA CORPORATION (JP) | 2011-08-23 | — | — | US | disclosed |
| US-7989463-B2 | Biccyclic compounds as GATA modulators | DR. REDDY'S LABORATORIES LIMITED (IN) | 2011-08-02 | — | — | US | disclosed |
| US-7960556-B2 | Thiadiazole derivatives for the treatment of neuro-degenerative diseases | NV REMYND (BE) | 2011-06-14 | — | — | US | disclosed |
| US-20110136191-A1 | Processes for producing coenzyme Q10 | KANEKA CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20110123505-A1 | METHOD OF PRODUCING REDUCED COENZYME Q10 AND METHOD OF STABILIZING THE SAME | KANEKA CORPORATION (JP) | 2011-05-26 | — | — | US | disclosed |
| WO-2011058474-A1 | N1-PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS | PFIZER INC. (US) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011058473-A1 | N2-PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS | PFIZER INC. (US) | 2011-05-19 | — | — | WO | disclosed |
| US-20110111046-A1 | N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors | PFIZER INC | 2011-05-12 | — | — | US | disclosed |
| CN-102056897-A | Sulfonamide compound and application thereof | ASAHI KASEI PHARMA CORP | 2011-05-11 | — | — | CN | disclosed |
| US-7910340-B2 | Extracting reduced/oxidized forms via microbial cells; solvent extraction; industrial scale | KANEKA CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| EP-2292592-A1 | SULFONAMIDE COMPOUND AND APPLICATION THEREOF | Asahi Kasei Pharma Corporation (JP) | 2011-03-09 | — | — | EP | disclosed |
| EP-2289866-A2 | Method of producing reduced coenzyme Q10 as oily product | Kaneka Corporation (JP) | 2011-03-02 | — | — | EP | disclosed |
| EP-2094677-B1 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES | REMYND NV (BE) | 2011-01-12 | — | — | EP | disclosed |
| US-20100292458-A1 | NOVEL PHOTOLABILE PROTECTIVE GROUPS FOR IMPROVED PROCESSES TO PREPARE OLIGONUCLEOTIDE ARRAYS | NIGU CHEMIE GMBH (DE) | 2010-11-18 | — | — | US | disclosed |
| US-20100292458-A1 | NOVEL PHOTOLABILE PROTECTIVE GROUPS FOR IMPROVED PROCESSES TO PREPARE OLIGONUCLEOTIDE ARRAYS | NIGU CHEMIE GMBH (DE) | 2010-11-18 | — | — | US | disclosed |
| US-7829080-B2 | Stabilization method of reduced coenzyme Q10 | KANEKA CORPORATION (JP) | 2010-11-09 | — | — | US | disclosed |
| EP-1408024-B1 | METHOD OF CRYSTALLIZING REDUCED COENZYME Q sb 10 /sb FROM AQUEOUS SOLUTION | KANEKA CORP (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20100261707-A9 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | NV REMYND (BE) | 2010-10-14 | — | — | US | disclosed |
| CN-101842340-A | Method for production of reduced coenzyme Q10 using water-containing organic solvent | KANEKA CORP | 2010-09-22 | — | — | CN | disclosed |
| US-20100234643-A1 | METHOD FOR PRODUCTION OF REDUCED COENZYME Q10 USING WATER-CONTAINING ORGANIC SOLVENT | KANEKA CORPORATION (JP) | 2010-09-16 | — | — | US | disclosed |
| EP-2228360-A1 | Method of producing reduced coenzyme Q10 using solvent with high oxidation-protective effect | KANEKA CORPORATION (JP) | 2010-09-15 | — | — | EP | disclosed |
| EP-1981504-B1 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES | REMYND NV (BE) | 2010-07-21 | — | — | EP | disclosed |
| CN-101219967-B | Process for producing 2-nitryl substituted benzene ethane nitrile compounds | SHANGHAI INST TECHNOLOGY | 2010-07-14 | — | — | CN | disclosed |
| US-20100144731-A1 | Novel Biccyclic Compounds As GATA Modulators | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-06-10 | — | — | US | disclosed |
| US-20100144709-A1 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES | NV REMYND (BE) | 2010-06-10 | — | — | US | disclosed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | disclosed |
| EP-2186789-A1 | METHOD OF PRODUCING REDUCED COENZYME Q10 AND METHOD OF STABILIZING THE SAME | Kaneka Corporation (JP) | 2010-05-19 | — | — | EP | disclosed |
| WO-2010028174-A1 | NOVEL BICCYCLIC COMPOUNDS AS GATA MODULATORS | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-03-11 | — | — | WO | disclosed |
| US-7660101-B2 | Electrolytic capacitor and electrolyte solution for use in an electrolytic capacitor | RUBYCON CORPORATION (JP) | 2010-02-09 | — | — | US | disclosed |
| US-20100022601-A1 | SULFONAMIDE COMPOUNDS AND THE USE | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-1415973-B1 | METHOD OF STABILIZING REDUCED COENZYME Q10 AND METHOD OF ACIDIC CRYSTALLIZATION | KANEKA CORP (JP) | 2010-01-13 | — | — | EP | disclosed |
| US-7592460-B2 | Colorant compositions | XEROX CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
| US-20090233911-A2 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | NV REMYND (BE) | 2009-09-17 | — | — | US | disclosed |
| EP-2094677-A1 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES | NV Remynd (BE) | 2009-09-02 | — | — | EP | disclosed |
| CN-100523205-C | Processes for producing coenzyme Q10 | KANEGAFUCHI CHEMICAL IND (JP) | 2009-08-05 | — | — | CN | disclosed |
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | disclosed |
| CN-101432256-A | Stable reduced coenzyme Q10Method (2) | KANEGAFUCHI CHEMICAL IND (JP) | 2009-05-13 | — | — | CN | disclosed |
| US-7524993-B2 | Method of producing reduced coenzyme Q10 as oily product | KANEKA CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20090054410-A1 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | NV REMYND (BE) | 2009-02-26 | — | — | US | disclosed |
| EP-2025662-A1 | METHOD FOR PURIFICATION OF REDUCED COENZYME Q10 | Kaneka Corporation (JP) | 2009-02-18 | — | — | EP | disclosed |
| EP-2017251-A1 | METHOD FOR STABILIZATION OF REDUCED COENZYME Q10 | Kaneka Corporation (JP) | 2009-01-21 | — | — | EP | disclosed |
| US-7470815-B1 | Selective neuronal nitric oxide synthase inhibitors | NORTHWESTERN UNIVERSITY (US) | 2008-12-30 | — | — | US | disclosed |
| US-20080306067-A1 | Modulators of Chemokine Receptor Activity | WEIGAND KLAUS | 2008-12-11 | — | — | US | disclosed |
| CN-101318889-A | Method of stabilizing reduced coenzyme Q10 | KANEGAFUCHI CHEMICAL IND (JP) | 2008-12-10 | — | — | CN | disclosed |
| CN-101296911-A | Arylurea derivatives as modulators of chemokine receptor activity | NOVARTIS AG (CH) | 2008-10-29 | — | — | CN | disclosed |
| EP-1981504-A2 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES | NV Remynd (BE) | 2008-10-22 | — | — | EP | disclosed |
| US-20080176830-A1 | Compounds, Compositions, and Methods | ADAMS NICHOLAS D | 2008-07-24 | — | — | US | disclosed |
| US-20080171373-A1 | Processes for producing coenzyme Q10 | KANEKA CORPORATION | 2008-07-17 | — | — | US | disclosed |
| EP-1943235-A1 | ARYLUREA DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Novartis AG (CH) | 2008-07-16 | — | — | EP | disclosed |
| CN-101219967-A | Process for producing 2-nitryl substituted benzene ethane nitrile compounds | SHANGHAI INST TECHNOLOGY (CN) | 2008-07-16 | — | — | CN | disclosed |
| EP-1471115-B1 | Methine dyes with a polyoxyalkylene moiety and inks containing them | XEROX CORP (US) | 2008-07-09 | — | — | EP | disclosed |
| WO-2008061781-A1 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES | NV REMYND (BE) | 2008-05-29 | — | — | WO | disclosed |
| CN-101189237-A | Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia | WARNER LAMBERT CO (US) | 2008-05-28 | — | — | CN | disclosed |
| US-20080099112-A1 | Reduced sensitivity melt-pourable Tritonal replacements | ALLIANT TECHSYSTEMS INC. | 2008-05-01 | — | — | US | disclosed |
| EP-1466983-B1 | PROCESSES FOR PRODUCING COENZYME Q10 | KANEKA CORP (JP) | 2008-03-05 | — | — | EP | disclosed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | disclosed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | disclosed |
| EP-1874753-A2 | COMPOUNDS, COMPOSITIONS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-01-09 | — | — | EP | disclosed |
| EP-1869041-A1 | TETRAHYDRO-PYRIDOAZEPIN-8-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA | Warner-Lambert Company LLC (US) | 2007-12-26 | — | — | EP | disclosed |
| US-20070258967-A1 | PURIFICATION METHOD OF REDUCED COENZYME Q10 | KANEKA CORPORATION (JP) | 2007-11-08 | — | — | US | disclosed |
| US-20070258966-A1 | STABILIZATION METHOD OF REDUCED COENZYME Q10 | KANEKA CORPORATION (JP) | 2007-11-08 | — | — | US | disclosed |
| CN-101061116-A | Sulfonamide compounds | JANSSEN PHARMACEUTICA NV (BE) | 2007-10-24 | — | — | CN | disclosed |
| CN-100344595-C | Purification of reduced coenzyme Q10Method (2) | KANEGAFUCHI CHEMICAL IND (JP) | 2007-10-24 | — | — | CN | disclosed |
| US-7279117-B2 | Electrolytic capacitor and electrolyte solution for use in an electrolytic capacitor | RUBYCON CORPORATION (JP) | 2007-10-09 | — | — | US | disclosed |
| US-7279484-B2 | Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease | AJINOMOTO CO., INC. (JP) | 2007-10-09 | — | — | US | disclosed |
| WO-2007090617-A2 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES | NV REMYND (BE) | 2007-08-16 | — | — | WO | disclosed |
| US-20070171595-A1 | Electrolytic capacitor and electrolyte solution for use in an electrolytic capacitor | RUBYCON CORPORATION (JP) | 2007-07-26 | — | — | US | disclosed |
| US-20070161825-A1 | Method of producing reduced coenzyme Q10 as oily product | KANEKA CORPORATION | 2007-07-12 | — | — | US | disclosed |
| EP-1415972-B1 | METHOD OF PRODUCING REDUCED COENZYME Q10 | KANEKA CORP (JP) | 2007-05-23 | — | — | EP | disclosed |
| WO-2007048771-A1 | ARYLUREA DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | NOVARTIS AG (CH) | 2007-05-03 | — | — | WO | disclosed |
| US-7208639-B2 | Method of producing reduced coenzyme Q10 as oily product | KANEKA CORPORATION (JP) | 2007-04-24 | — | — | US | disclosed |
| US-20070029529-A1 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | KOMATSU AKIHIKO | 2007-02-08 | — | — | US | disclosed |
| EP-1401813-B1 | NEW INDOLE DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY | HOFFMANN LA ROCHE (CH) | 2007-02-07 | — | — | EP | disclosed |
| US-7169590-B2 | Method of stabilizing reduced coenzyme Q10 and method of acidic crystallization | KANEKA CORPORATION (JP) | 2007-01-30 | — | — | US | disclosed |
| US-7145044-B2 | Method of producing reduced coenzyme Q10 using solvent with high oxidation-protective effect | KANEKA CORPORATION (JP) | 2006-12-05 | — | — | US | disclosed |
| US-20060246565-A1 | Method of purifying reduced coenzyme q | KANEKA CORPORATION (JP) | 2006-11-02 | — | — | US | disclosed |
| WO-2006113432-A2 | COMPOUNDS, COMPOSITIONS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2006-10-26 | — | — | WO | disclosed |
| US-20060234997-A1 | Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia | WARNER-LAMBERT COMPANY LLC | 2006-10-19 | — | — | US | disclosed |
| WO-2006103559-A1 | TETRAHYDRO-PYRIDOAZEPIN-8-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA | WARNER-LAMBERT COMPANY LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| US-7105709-B2 | Method of producing reduced coenzyme q10 | KANEKA CORPORATION (JP) | 2006-09-12 | — | — | US | disclosed |
| EP-1583729-A4 | METHOD OF PURIFYING REDUCED COENZYME Q | KANEKA CORP (JP) | 2006-07-05 | — | — | EP | disclosed |
| US-7067024-B2 | Reduced sensitivity, melt-pourable TNT replacements | ALLIANT TECHSYSTEMS INC. (US) | 2006-06-27 | — | — | US | disclosed |
| CN-1257892-C | New indole derivatives with 5-HT6 receptor affinity | HOFFMANN LA ROCHE (CH) | 2006-05-31 | — | — | CN | disclosed |
| CN-1254462-C | Reduced coenzyme Q10Method for stabilization of (3) and method for acid crystallization | KANEGAFUCHI CHEMICAL IND (JP) | 2006-05-03 | — | — | CN | disclosed |
| US-7034185-B2 | Colorant precursor compositions | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | disclosed |
| CN-1723181-A | Method of purifying reduced coenzyme Q | KANEGAFUCHI CHEMICAL IND (JP) | 2006-01-18 | — | — | CN | disclosed |
| US-20050277630-A1 | Antibacterial agents | CHUPAK LOUIS S | 2005-12-15 | — | — | US | disclosed |
| CN-1228307-C | O-nitrophenylacetic acid and catalysis synthesis of phase transfer | UNIV TAIYUAN TECHNOLOGY (CN) | 2005-11-23 | — | — | CN | disclosed |
| EP-1594495-A1 | OXAZOLIDINONE DERIVATES N-SUBSTITUTED BY A TRICYCLIC RING, FOR USE AS ANTIBACTERIAL AGENTS | Warner-Lambert Company LLC (US) | 2005-11-16 | — | — | EP | disclosed |
| US-6964714-B2 | Reduced sensitivity, melt-pourable tritonal replacements | ALLIANT TECHSYSTEMS INC. (US) | 2005-11-15 | — | — | US | disclosed |
| US-20050250796-A1 | Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease | AJINOMOTO CO., INC. (JP) | 2005-11-10 | — | — | US | disclosed |
| EP-1367058-B1 | Tetrahydropyran derivatives | ASTELLAS PHARMA INC (JP) | 2005-11-09 | — | — | EP | disclosed |
| US-20050239780-A1 | Tetrahydropyran derivative | ASTELLAS PHARMA INC. (JP) | 2005-10-27 | — | — | US | disclosed |
| EP-1583729-A1 | METHOD OF PURIFYING REDUCED COENZYME Q | KANEKA CORPORATION (JP) | 2005-10-12 | — | — | EP | disclosed |
| CN-1656091-A | Tetrahydropyran derivatives | YAMANOUCHI PHARMA CO LTD (JP) | 2005-08-17 | — | — | CN | disclosed |
| US-20050171118-A1 | New indole derivatives with 5-HT6 receptor affinity | BEARD COLIN C (US) | 2005-08-04 | — | — | US | disclosed |
| US-20050171131-A1 | Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists | KOSOGOF CHRISTI (US) | 2005-08-04 | — | — | US | disclosed |
| US-20050159363-A1 | Selective neuronal nitric oxide synthase inhibitors | SILVERMAN RICHARD B (US) | 2005-07-21 | — | — | US | disclosed |
| US-20050094352-A1 | Electrolytic capacitor and electrolitic solution for driving electrolytic capacitor | RUBYCON CORPORATION (JP) | 2005-05-05 | — | — | US | disclosed |
| CN-1608136-A | Processes for producing coenzyme Q10 | KANEKA CORP (JP) | 2005-04-20 | — | — | CN | disclosed |
| US-20050069996-A1 | Extracting reduced/oxidized forms via microbial cells | KANEKA CORPORATION (JP) | 2005-03-31 | — | — | US | disclosed |
| US-20050070712-A1 | Pyrimidine derivatives as ghrelin receptor modulators | ABBOTT LABORATORIES | 2005-03-31 | — | — | US | disclosed |
| CN-1578760-A | Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor | IHARA CHEMICAL IND CO (JP) | 2005-02-09 | — | — | CN | disclosed |
| CN-1572754-A | Method for producing organic compound by substituting halogen atoms | MITSUI CHEMICALS INC (JP) | 2005-02-02 | — | — | CN | disclosed |
| US-20050008630-A1 | Preservation; nutrients; foods; using ascorbic and citric acid; oxidation resistance; by-product inhibition | KANEKA CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20040256743-A1 | Method for producing organic compound by substituting halogen atoms | MITSUI CHEMICALS, INC. (JP) | 2004-12-23 | — | — | US | disclosed |
| US-20040254403-A1 | Method of producing reduced coenzyme q10 as oily product | KANEKA CORPORATION (JP) | 2004-12-16 | — | — | US | disclosed |
| EP-1486479-A1 | Method for producing organic compounds by substituting halogen atoms | MITSUI CHEMICALS, INC. (JP) | 2004-12-15 | — | — | EP | disclosed |
| US-20040245105-A1 | Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2004-12-09 | — | — | US | disclosed |
| US-20040248902-A1 | New indole derivatives with 5-HT6 receptor affinity | BEARD COLIN CHARLES (US) | 2004-12-09 | — | — | US | disclosed |
| US-20040236154-A1 | Method of producing reduced coenzyme q10 | KANEKA CORPORATION (JP) | 2004-11-25 | — | — | US | disclosed |
| US-20040215038-A1 | Colorant precursor compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | disclosed |
| US-20040214301-A1 | Using cooled ethanol and acetone mixtures to generate and isolate coenzyme q10 crystals for use in nutritive foods, drinks, feeds, cosmetics and medicines | KANEKA CORPORATION (JP) | 2004-10-28 | — | — | US | disclosed |
| US-20040215040-A1 | Method of producing reduced coenzyme q10 using solvent with high oxidation-protective effect | KANEKA CORPORATION (JP) | 2004-10-28 | — | — | US | disclosed |
| US-20040215022-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | disclosed |
| EP-1471115-A1 | Methine dyes with a polyoxyalkylene moiety and inks containing them | Xerox Corporation (US) | 2004-10-27 | — | — | EP | disclosed |
| EP-1471118-A1 | Colorant precursor compounds containing one polyoxyalkylene group | Xerox Corporation (US) | 2004-10-27 | — | — | EP | disclosed |
| EP-1466983-A1 | PROCESSES FOR PRODUCING COENZYME Q SB 10 /SB | KANEKA CORPORATION (JP) | 2004-10-13 | — | — | EP | disclosed |
| US-6803486-B2 | PEPTIDOMIMETIC; N-AMINOBUTYL-N'-NITROGUANIDINE DERIVATIVES | NORTHWESTERN UNIVERSITY | 2004-10-12 | — | — | US | disclosed |
| US-20040199002-A1 | Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor | INDUSTRY CO., LTD. (JP) | 2004-10-07 | — | — | US | disclosed |
| US-20040197886-A1 | Method of crystallizing reduced coenzyme Q10 from aqueous solution | KANEKA CORPORATION (JP) | 2004-10-07 | — | — | US | disclosed |
| US-20040197418-A1 | Method of stabilizing reduced coenzyme q10 and method of acidic crystallization | KANEKA CORPORATION (JP) | 2004-10-07 | — | — | US | disclosed |
| EP-1460660-A1 | ELECTROLYTIC CAPACITOR AND ELECTROLITIC SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-6790267-B1 | METHINE COLORANT COMPOUNDS FOR PHASE CHANGE INKS | XEROX CORPORATION | 2004-09-14 | — | — | US | disclosed |
| CN-1527816-A | Novel indole derivatives having 5-HT 6 receptor affinity | - | 2004-09-08 | — | — | CN | disclosed |
| US-6787535-B2 | CENTRAL NERVOUS SYSTEM DISORDERS; PARKINSON'S DISEASE, HUNTINGTON'S DISEASE; PSYCOLOGICAL DISORDERS | SYNTEX (U.S.A.) LLC | 2004-09-07 | — | — | US | disclosed |
| EP-1452174-A1 | METHOD OF STABILIZING REDUCED COENZYME Q sb 10 /sb | KANEKA CORPORATION (JP) | 2004-09-01 | — | — | EP | disclosed |
| CN-1525951-A | Reduced coenzyme Q10Method for stabilization of (3) and method for acid crystallization | ��Ԩ��ѧ��ҵ��ʽ���� | 2004-09-01 | — | — | CN | disclosed |
| WO-2004069245-A1 | OXAZOLIDINONE DERIVATES N-SUBSTITUTED BY A TRICYCLIC RING, FOR USE AS ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY LLC (US) | 2004-08-19 | — | — | WO | disclosed |
| WO-2004063131-A1 | METHOD OF PURIFYING REDUCED COENZYME Q | KANEKA CORPORATION (JP) | 2004-07-29 | — | — | WO | disclosed |
| EP-1437749-A1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-07-14 | — | — | EP | disclosed |
| EP-1431278-A1 | PROCESS FOR PRODUCING (2-NITROPHENYL)ACETONITRILE DERIVATIVE AND INTERMEDIATE THEREFOR | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2004-06-23 | — | — | EP | disclosed |
| EP-1415971-A1 | METHOD OF PRODUCING REDUCED COENZYME Q10 AS OILY PRODUCT | KANEKA CORPORATION (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1415969-A1 | METHOD OF PRODUCING REDUCED COENZYME Q10 USING SOLVENT WITH HIGH OXIDATION-PROTECTIVE EFFECT | KANEKA CORPORATION (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1415973-A1 | METHOD OF STABILIZING REDUCED COENZYME Q10 AND METHOD OF ACIDIC CRYSTALLIZATION | KANEKA CORPORATION (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1415972-A1 | METHOD OF PRODUCING REDUCED COENZYME Q10 | KANEKA CORPORATION (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1415970-A1 | METHOD OF PRODUCING REDUCED COENZYME Q10 CRYSTALS WITH EXCELLENT HANDLING PROPERTIES | KANEKA CORPORATION (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1408024-A1 | METHOD OF CRYSTALLIZING REDUCED COENZYME Q sb 10 /sb FROM AQUEOUS SOLUTION | KANEKA CORPORATION (JP) | 2004-04-14 | — | — | EP | disclosed |
| EP-1401813-A1 | NEW INDOLE DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY | F. Hoffman-la Roche AG (CH) | 2004-03-31 | — | — | EP | disclosed |
| EP-1399400-A1 | REDUCED SENSITIVITY, MELT-POURABLE TNT REPLACEMENTS | ALLIANT TECHSYSTEMS INC. (US) | 2004-03-24 | — | — | EP | disclosed |
| EP-1399399-A1 | REDUCED SENSITIVITY, MELT-POURABLE TRITONAL REPLACEMENTS | ALLIANT TECHSYSTEMS INC. (US) | 2004-03-24 | — | — | EP | disclosed |
| CN-1138763-C | Di- or tri-fluoromethanesulfonyl anilide derivs., process for preparation of them and herbicides contg. them as active ingredient | ��Ԩ��ѧ��ҵ��ʽ���� | 2004-02-18 | — | — | CN | disclosed |
| US-20040009976-A1 | Hypoglycemic imidazoline compounds | TAKEUCHI KUMIKO (US) | 2004-01-15 | — | — | US | disclosed |
| CN-1462738-A | O-nitrophenylacetic acid and catalysis synthesis of phase transfer | TAIYUAN TECHNICAL UNIV (CN) | 2003-12-24 | — | — | CN | disclosed |
| EP-1367058-A1 | Tetrahydropyran derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 2003-12-03 | — | — | EP | disclosed |
| EP-1361218-A1 | Trifluoromethanesulfonyl anilide derivatives, process for the preparation of them and herbicides containing them as the active ingredient | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2003-11-12 | — | — | EP | disclosed |
| EP-1101760-B1 | DIFLUOROMETHANESULFONYL ANILIDE DERIVATIVES, PROCESS FOR THE PREPARATION OF THEM AND HERBICIDES CONTAINING THEM AS THE ACTIVE INGREDIENT | IHARA CHEMICAL IND CO (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-20030140993-A1 | Reduced sensitivity, melt-pourable tritonal replacements | NORTHROP GRUMMAN SYSTEMS CORPORATION | 2003-07-31 | — | — | US | disclosed |
| CN-1115329-C | Process for preparing p-nitrophenyl acetonitrile by directional nitrification | WEI CHANGMEI (CN) | 2003-07-23 | — | — | CN | disclosed |
| US-20030119751-A1 | Selective neuronal nitric oxide synthase inhibitors | NORTHWESTERN UNIVERSITY | 2003-06-26 | — | — | US | disclosed |
| JP-2003171359-A | METHOD FOR PRODUCING 2-NITROPHENYLACETONITRILE DERIVATIVE, AND ITS SYNTHETIC INTERMEDIATE | IHARA CHEM IND CO LTD | 2003-06-20 | — | — | JP | disclosed |
| EP-0924209-B1 | Hypoglycemic imidazoline compounds | LILLY CO ELI (US) | 2003-05-02 | — | — | EP | disclosed |
| US-20030073700-A1 | New indole derivatives with 5HT6 receptor affinity | SYNTEX (U.S.A.) LLC, NAME CHANGE TO ROCHE PALO ALTO LLC | 2003-04-17 | — | — | US | disclosed |
| WO-2003002486-A1 | REDUCED SENSITIVITY, MELT-POURABLE TNT REPLACEMENTS | ALLIANT TECHSYSTEMS INC. (US) | 2003-01-09 | — | — | WO | disclosed |
| WO-2003002485-A1 | REDUCED SENSITIVITY, MELT-POURABLE TRITONAL REPLACEMENTS | ALLIANT TECHSYSTEMS INC. (US) | 2003-01-09 | — | — | WO | disclosed |
| US-20030005988-A1 | Reduced sensitivity, melt-pourable TNT replacements | NORTHROP GRUMMAN SYSTEMS CORPORATION | 2003-01-09 | — | — | US | disclosed |
| WO-2003000198-A2 | SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS | NORTHWESTERN UNIVERSITY (US) | 2003-01-03 | — | — | WO | disclosed |
| EP-1266897-A2 | Hypoglycemic imidazoline compounds | ELI LILLY AND COMPANY (US) | 2002-12-18 | — | — | EP | disclosed |
| WO-2002098857-A1 | NEW INDOLE DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY | F. HOFFMANN-LA ROCHE AG (CH) | 2002-12-12 | — | — | WO | disclosed |
| US-6458748-B1 | COMPOUND WHICH IS EFFECTIVE FOR THE REMOVAL OF A WIDE VARIETY OF WEEDS INCLUDING DIFFICULT-TO-CONTROL WEEDS EMERGING IN PADDY FIELD AND WHICH IS SAFE TO MAMMALS; A PROCESS FOR PRODUCTION THEREOF; A HERBICIDE CONTAINING THE COMPOUND AS AN | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2002-10-01 | — | — | US | disclosed |
| US-6455522-B1 | ANTIINFLAMMATORY AGENTS; AGGRECANASE AND TUMOR NECROSIS FACTOR INHIBITORS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-09-24 | — | — | US | disclosed |
| US-6410562-B1 | ANTIDIABETIC AGENTS | ELI LILLY AND COMPANY | 2002-06-25 | — | — | US | disclosed |
| EP-0796852-B1 | Process for preparation of 5-substituted tetrazoles | TOYO KASEI KOGYO CO LTD (JP) | 2001-10-24 | — | — | EP | disclosed |
| CN-1309646-A | Di- or tri-fluoromethanesulfonyl anilide derivs., process for preparation of them and herbicides contg. them as active ingredient | IHARA CHEMICAL IND CO (JP) | 2001-08-22 | — | — | CN | disclosed |
| CN-1305988-A | Process for preparing p-nitrophenyl acetonitrile by directional nitrification | WEI CHANGMEI (CN) | 2001-08-01 | — | — | CN | disclosed |
| EP-1101760-A1 | DI- OR TRI-FLUOROMETHANESULFONYL ANILIDE DERIVATIVES, PROCESS FOR THE PREPARATION OF THEM AND HERBICIDES CONTAINING THEM AS THE ACTIVE INGREDIENT | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2001-05-23 | — | — | EP | disclosed |
| US-6179883-B1 | USING 2-IMINO-2,3-DIHYDRO-1H-INDOLE MIXTURE | L'OREAL (FR) | 2001-01-30 | — | — | US | disclosed |
| EP-1054877-A1 | NOVEL CYCLIC SULFONAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS | Du Pont Pharmaceuticals Company (US) | 2000-11-29 | — | — | EP | disclosed |
| US-6040454-A | REACTING 1-(CYANOBIPHENYLMETHYL)IMIDAZOLE DERIVATIVE WITH AN ALKALI OR ALKALINE EARTH METAL AZIDE SALT IN AN AROMATIC HYDROCARBON SOLVENT IN PRESENCE OF AN AMINE SALT | TOYO KASEI KOGYO COMPANY LIMITED (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5962492-A | ANTIASTHMA AGENTS; ANTIINFLAMMATORY AGENTS | CELLTECH THERAPEUTICS LIMITED (GB) | 1999-10-05 | — | — | US | disclosed |
| WO-1999041246-A1 | NOVEL CYCLIC SULFONAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS | DU PONT PHARMACEUTICALS COMPANY (US) | 1999-08-19 | — | — | WO | disclosed |
| US-5919469-A | Products derived from 2-imino-2,3-dihydro-1H-indoles, processes for their preparation, their use in cosmetics and cosmetic compositions using them | L'OREAL (FR) | 1999-07-06 | — | — | US | disclosed |
| WO-1999032482-A1 | HYPOGLYCEMIC IMIDAZOLINE COMPOUNDS | ELI LILLY AND COMPANY (US) | 1999-07-01 | — | — | WO | disclosed |
| EP-0826669-B1 | Composition for dyeing keratin fibres containing 2-iminoindol derivatives | OREAL (FR) | 1999-06-30 | — | — | EP | disclosed |
| EP-0924209-A1 | Hypoglycemic imidazoline compounds | ELI LILLY AND COMPANY (US) | 1999-06-23 | — | — | EP | disclosed |
| US-5908932-A | Certain pyrroloquinolinones; a new class of GABA brain receptor | NEUROGEN CORPORATION (US) | 1999-06-01 | — | — | US | disclosed |
| US-5876465-A | Compositions for dyeing keratin fibres containing 2-iminoindoline derivatives and dyeing process | L'OREAL (FR) | 1999-03-02 | — | — | US | disclosed |
| EP-0887346-A2 | Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists | F. HOFFMANN-LA ROCHE AG (CH) | 1998-12-30 | — | — | EP | disclosed |
| US-5744612-A | Process for preparation of 5- substituted tetrazoles | TOYO KASEI KOGYO COMPANY LIMITED (JP) | 1998-04-28 | — | — | US | disclosed |
| EP-0826669-A1 | Composition for dyeing keratin fibres | L'OREAL (FR) | 1998-03-04 | — | — | EP | disclosed |
| US-5723460-A | Cyclo (alkyl and alkenyl) phenyl-alkenylyl heteroaryl compounds and pharmaceutical compositions containing same | CELLTECH THERAPEUTICS LIMITED (GB) | 1998-03-03 | — | — | US | disclosed |
| EP-0796852-A1 | Process for preparation of 5-substituted tetrazoles | Toyo Kasei Kogyo Company Limited (JP) | 1997-09-24 | — | — | EP | disclosed |
| EP-0640070-B1 | STYRYL DERIVATIVES, THEIR PREPARATION AND USE AS PDE-IV INHIBITORS | CELLTECH THERAPEUTICS LTD (GB) | 1997-09-10 | — | — | EP | disclosed |
| US-5633257-A | PHOSPHODIESTERASE INHIBITOR | CELLTECH THERAPEUTICS LIMITED (GB) | 1997-05-27 | — | — | US | disclosed |
| US-5622137-A | FOR USE IN TESTING COOKED FOODS | TRANS WORLD SERVICES (US) | 1997-04-22 | — | — | US | disclosed |
| US-5604235-A | DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, BENZODIAZEPINE OVERDOSE; ENHANCEMENT OF MEMORY | NEUROGEN CORPORATION (US) | 1997-02-18 | — | — | US | disclosed |
| WO-1996004246-A1 | PHENYLACETAMIDES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION | LABORATORIOS MENARINI S.A. (ES) | 1996-02-15 | — | — | WO | disclosed |
| EP-0687697-A2 | A carbonate group-modified epoxy resin and thermosetting compositions of resins containing hydroxyalkyl carbonate groups | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1995-12-20 | — | — | EP | disclosed |
| EP-0669320-A2 | Benzoylquinoiline derivatives | NIHON BAYER AGROCHEM K.K. (JP) | 1995-08-30 | — | — | EP | disclosed |
| EP-0640070-A1 | STYRYL DERIVATIVES, THEIR PREPARATION AND USE AS PDE-IV INHIBITORS. | CELLTECH THERAPEUTICS LTD (GB) | 1995-03-01 | — | — | EP | disclosed |
| WO-1994026741-A1 | CERTAIN PYRROLOQUINOLINONES; A NEW CLASS OF GABE BRAIN RECEPTOR LIGANDS | NEUROGEN CORPORATION (US) | 1994-11-24 | — | — | WO | disclosed |
| WO-1994020455-A1 | STYRYL DERIVATIVES, THEIR PREPARATION AND USE AS PDE-IV INHIBITORS | CELLTECH THERAPEUTICS LIMITED (GB) | 1994-09-15 | — | — | WO | disclosed |
| EP-0307804-B1 | Cephem compound and a process for preparation thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1993-11-18 | — | — | EP | disclosed |
| US-5243049-A | Gamma-aminobutyric acid antagonist | NEUROGEN CORPORATION (US) | 1993-09-07 | — | — | US | disclosed |
| EP-0299379-B1 | PENTADIENAMIDE PAF-ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 1993-04-21 | — | — | EP | disclosed |
| US-5175273-A | Pyridinone or pyrimidinone nucleoside bases containing fused aromatic polycyclic rings | GENENTECH, INC. (US) | 1992-12-29 | — | — | US | disclosed |
| US-4975438-A | ANTICOAGULANT | HOFFMANN-LA ROCHE INC. (US) | 1990-12-04 | — | — | US | disclosed |
| US-4956465-A | Bactericides | BAYER AKTIENGESELLSCHAFT (DE) | 1990-09-11 | — | — | US | disclosed |
| US-4927826-A | Cycloproylpropenamides useful as platelet activing factor (PAF) antagonists | HOFFMAN-LA ROCHE INC. (US) | 1990-05-22 | — | — | US | disclosed |
| US-4927838-A | CARDIOVASCULAR DISORDERS | HOFFMAN-LA ROCHE INC. (US) | 1990-05-22 | — | — | US | disclosed |
| US-4916145-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | HOFFMANN-LA ROCHE INC. (US) | 1990-04-10 | — | — | US | disclosed |
| EP-0129509-B1 | TRIAZOLO (2,3-C)(1,3)BENZODIAZEPINES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR THERAPEUTICAL USE | CIBA-GEIGY AG (CH) | 1989-08-23 | — | — | EP | disclosed |
| EP-0310917-A2 | Quinolonecarboxylic acids bearing C(7) carbon-functionality and a method for their preparation | BAYER AG (DE) | 1989-04-12 | — | — | EP | disclosed |
| EP-0307804-A2 | Cephem compound and a process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-03-22 | — | — | EP | disclosed |
| EP-0299379-A1 | Pentadienamide PAF-antagonists | F. HOFFMANN-LA ROCHE AG (CH) | 1989-01-18 | — | — | EP | disclosed |
| US-4788206-A | CARDIOVASCULAR DISORDERS, PLATELETS | HOFFMANN-LA ROCHE INC. (US) | 1988-11-29 | — | — | US | disclosed |
| US-4786646-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | HOFFMANN-LA ROCHE INC. (US) | 1988-11-22 | — | — | US | disclosed |
| US-4725497-A | Unfalsifiable safety paper | SOCIETE ANONYME: AUSSEDAT-REY (FR) | 1988-02-16 | — | — | US | disclosed |
| EP-0078709-B1 | PREPARATION OF NITROARALKYL CYANIDES AND DERIVATIVES THEREOF | ETHYL CORPORATION (US) | 1986-10-01 | — | — | EP | disclosed |
| US-4595535-A | Schizophrenia | CIBA-GEIGY CORPORATION (US) | 1986-06-17 | — | — | US | disclosed |
| EP-0077662-B1 | PREPARATION OF NITROARYLACETIC ACID ESTERS AND DERIVATIVES THEREOF | ETHYL CORPORATION (US) | 1985-10-02 | — | — | EP | disclosed |
| US-4507311-A | Imidazo[1,2-c][1,3]benzodiazepines | CIBA-GEIGY CORPORATION (US) | 1985-03-26 | — | — | US | disclosed |
| US-4502998-A | Nucleophilic substitution process | ETHYL CORPORATION (US) | 1985-03-05 | — | — | US | disclosed |
| US-4499026-A | Nucleophilic substitution process | ETHYL CORPORATION (US) | 1985-02-12 | — | — | US | disclosed |
| EP-0129509-A2 | Triazolo (2,3-c)(1,3)benzodiazepines, process for their preparation, pharmaceutical compositions containing them and their therapeutical use | CIBA-GEIGY AG (CH) | 1984-12-27 | — | — | EP | disclosed |
| EP-0122109-A2 | Preparation of cyano- or aminoalkyl substituted aromatic amines | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1984-10-17 | — | — | EP | disclosed |
| US-4476315-A | NITROARYLACETIC ACID ESTERS FROM NITROAROMATIC COMPOUNDS | ETHYL CORPORATION (US) | 1984-10-09 | — | — | US | disclosed |
| US-4460587-A | ANTIPSYCHOTIC AGENTS, ANTIALLERGENS | CIBA-GEIGY CORPORATION (US) | 1984-07-17 | — | — | US | disclosed |
| US-4460508-A | 5-Diazacycloalkylimidazo[1,2-c][1,3]benzodiazepines | CIBA-GEIGY CORPORATION (US) | 1984-07-17 | — | — | US | disclosed |
| US-4459232-A | NEUROLEPTIC, ANTIHISTAMINES | CIBA-GEIGY CORPORATION (US) | 1984-07-10 | — | — | US | disclosed |
| EP-0081461-A2 | Imidazobenzodiazepines, process for their preparation, pharmaceutical preparations containing these compounds and their therapeutical use | CIBA-GEIGY AG (CH) | 1983-06-15 | — | — | EP | disclosed |
| EP-0078709-A2 | Preparation of nitroaralkyl cyanides and derivatives thereof | ETHYL CORPORATION (US) | 1983-05-11 | — | — | EP | disclosed |
| EP-0077662-A1 | Preparation of nitroarylacetic acid esters and derivatives thereof | ETHYL CORPORATION (US) | 1983-04-27 | — | — | EP | disclosed |
| JP-S5562061-A | PRODUCTION OF INDOLES | IHARA CHEM IND CO LTD | 1980-05-10 | — | — | JP | disclosed |
| JP-S54126726-A | HERBICIDE | TANABE SEIYAKU CO LTD | 1979-10-02 | — | — | JP | disclosed |
| US-4064136-A | FROM A NITRILE, AN ALCOHOL AND ORTHO-SUBSTITUTED AROMATIC AMINE | CIBA-GEIGY AG (CH) | 1977-12-20 | — | — | US | disclosed |
| US-4064136-A | FROM A NITRILE, AN ALCOHOL AND ORTHO-SUBSTITUTED AROMATIC AMINE | CIBA-GEIGY AG (CH) | 1977-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (40 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306067-A1 | Modulators of Chemokine Receptor Activity | CCR3, CCR1, CCR4 | ALDH1A1 906/4885HPGD 388/4885TSHR 1110/4885 |
| US-20100144731-A1 | Novel Biccyclic Compounds As GATA Modulators | GATAD2A, GATAD2B, RUNX1 | ALDH1A1 3621/4885HPGD 4556/4885TSHR 3441/4885 |
| US-20040009976-A1 | Hypoglycemic imidazoline compounds | GPR119, IAPP, GLP1R | ALDH1A1 1932/4885HPGD 1814/4885TSHR 1681/4885 |
| US-20050159363-A1 | Selective neuronal nitric oxide synthase inhibitors | NOS1, NOS3, NOS2 | ALDH1A1 1959/4885HPGD 225/4885TSHR 3793/4885 |
| US-20050277630-A1 | Antibacterial agents | MRPL21, RPN2, FBL | ALDH1A1 637/4885HPGD 419/4885TSHR 4486/4885 |
| US-20160166681-A1 | TOLL-LIKE RECEPTOR AGONISTS | TLR1, TLR7, TLR8 | ALDH1A1 1952/4885HPGD 2868/4885TSHR 1137/4885 |
| US-20040215022-A1 | Colorant compositions | ARSA, TST, IK | ALDH1A1 1311/4885HPGD 2922/4885TSHR 1005/4885 |
| US-20160113277-A1 | Substituted 5-Hydroxy-2,3-Diphenylpentanonitrile Derivatives, Processes For Their Preparation And Their Use As Herbicides And/Or Plant Growth Regulators | HPD, DDT, HDHD5 | ALDH1A1 117/4885HPGD 222/4885TSHR 1679/4885 |
| US-20080176830-A1 | Compounds, Compositions, and Methods | ALPP, PCNA, MKI67 | ALDH1A1 2274/4885HPGD 802/4885TSHR 4737/4885 |
| US-10239811-B2 | Process for producing reduced coenzyme Q10 | NDUFA10, NDUFB10, NDUFA9 | ALDH1A1 640/4885HPGD 101/4885TSHR 4853/4885 |
| US-20040256743-A1 | Method for producing organic compound by substituting halogen atoms | MRPS22, QARS1, MTX2 | ALDH1A1 1159/4885HPGD 3905/4885TSHR 3163/4885 |
| US-20140288111-A1 | N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS | ACACA, PC, ACACB | ALDH1A1 164/4885HPGD 588/4885TSHR 3693/4885 |
| US-20050239780-A1 | Tetrahydropyran derivative | APOB, HDLBP, LDLR | ALDH1A1 4266/4885HPGD 1530/4885TSHR 2064/4885 |
| US-20100292458-A1 | NOVEL PHOTOLABILE PROTECTIVE GROUPS FOR IMPROVED PROCESSES TO PREPARE OLIGONUCLEOTIDE ARRAYS | NT5C3B, NSUN2, ERCC4 | ALDH1A1 867/4885HPGD 1761/4885TSHR 3311/4885 |
| US-20090233911-A2 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | SNCA, HTT, PARK7 | ALDH1A1 1930/4885HPGD 1746/4885TSHR 3338/4885 |
| US-20110111046-A1 | N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors | ACACA, PC, ACACB | ALDH1A1 164/4885HPGD 588/4885TSHR 3693/4885 |
| US-20050171131-A1 | Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists | GHSR, GIPR, GPR119 | ALDH1A1 2435/4885HPGD 231/4885TSHR 348/4885 |
| US-20130296319-A1 | N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS | ACACA, PC, ACACB | ALDH1A1 161/4885HPGD 560/4885TSHR 3681/4885 |
| US-20230110251-A1 | NON-AQUEOUS ELECTROLYTE FOR BATTERY, PRECURSOR FOR LITHIUM SECONDARY BATTERY, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY, PHOSPHAZENE COMPOUND, AND ADDITIVE FOR BATTERY | PHOSPHO1, SLC9B2, SLC9A2 | ALDH1A1 3982/4885HPGD 2713/4885TSHR 732/4885 |
| US-20040248902-A1 | New indole derivatives with 5-HT6 receptor affinity | HTR6, HTR5A, HTR7 | ALDH1A1 1833/4885HPGD 2230/4885TSHR 182/4885 |
| US-20120276651-A1 | FLUORESCENT NANOPROBE FOR DETECTING HYDROGEN PEROXIDE AND FABRICATION METHOD THEREOF | GPX4, PPOX, SQOR | ALDH1A1 319/4885HPGD 89/4885TSHR 2789/4885 |
| US-20050250796-A1 | Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease | TNF, NOD2, LITAF | ALDH1A1 3789/4885HPGD 1359/4885TSHR 1891/4885 |
| US-10021877-B2 | Substituted 5-hydroxy-2,3-diphenylpentanonitrile derivatives, processes for their preparation and their use as herbicides and/or plant growth regulators | HPD, DDT, HDHD5 | ALDH1A1 117/4885HPGD 222/4885TSHR 1679/4885 |
| US-20150307440-A1 | REDUCED COENZYME Q10 DERIVATIVE AND METHOD FOR PRODUCTION THEREOF | NDUFA10, NDUFB10, NDUFAF2 | ALDH1A1 719/4885HPGD 244/4885TSHR 3354/4885 |
| US-20180134644-A1 | PROCESS FOR PRODUCING REDUCED COENZYME Q10 | NDUFA10, NDUFB10, NDUFA9 | ALDH1A1 640/4885HPGD 101/4885TSHR 4853/4885 |
| US-20030119751-A1 | Selective neuronal nitric oxide synthase inhibitors | NOS1, NOS3, NOS2 | ALDH1A1 1959/4885HPGD 225/4885TSHR 3793/4885 |
| US-20050171118-A1 | New indole derivatives with 5-HT6 receptor affinity | HTR6, HTR5A, HTR7 | ALDH1A1 2354/4885HPGD 2558/4885TSHR 137/4885 |
| US-20060234997-A1 | Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia | PTGDR, GRIN2A, PTGDR2 | ALDH1A1 826/4885HPGD 79/4885TSHR 861/4885 |
| US-20040199002-A1 | Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor | DOHH, NCEH1, NOTUM | ALDH1A1 371/4885HPGD 90/4885TSHR 4200/4885 |
| US-20100261707-A9 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | SNCA, HTT, PARK7 | ALDH1A1 1930/4885HPGD 1746/4885TSHR 3338/4885 |
| US-20050070712-A1 | Pyrimidine derivatives as ghrelin receptor modulators | GPR119, GIPR, GCGR | ALDH1A1 2333/4885HPGD 893/4885TSHR 161/4885 |
| US-10471139-B2 | Toll-like receptor agonists | TLR1, TLR7, TLR8 | ALDH1A1 1952/4885HPGD 2868/4885TSHR 1137/4885 |
| US-20260131016-A1 | NOVEL AURISTATIN ANALOGS AND IMMUNOCONJUGATES THEREOF | FCGR2A, FCGR3B, AURKC | ALDH1A1 3068/4885HPGD 4647/4885TSHR 142/4885 |
| US-20130030181-A1 | N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors | ACACA, PC, ACACB | ALDH1A1 164/4885HPGD 588/4885TSHR 3693/4885 |
| US-20120225900-A1 | N2-PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS | ACACA, PC, ACACB | ALDH1A1 259/4885HPGD 544/4885TSHR 3659/4885 |
| US-20100022601-A1 | SULFONAMIDE COMPOUNDS AND THE USE | PTH1R, CASR, SOST | ALDH1A1 3531/4885HPGD 2157/4885TSHR 17/4885 |
| US-20030073700-A1 | New indole derivatives with 5HT6 receptor affinity | HTR6, HTR5A, HTR7 | ALDH1A1 1394/4885HPGD 2411/4885TSHR 176/4885 |
| US-20040215038-A1 | Colorant precursor compositions | RB1, SULT1A1, CBR1 | ALDH1A1 199/4885HPGD 1780/4885TSHR 2621/4885 |
| US-20090054410-A1 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | SNCA, HTT, PARK7 | ALDH1A1 1930/4885HPGD 1746/4885TSHR 3338/4885 |
| US-20100144709-A1 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES | SNCA, PARK7, PRNP | ALDH1A1 608/4885HPGD 271/4885TSHR 3125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.